• Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Money Profit News
No Result
View All Result
Home Breaking News

Moderna says an omicron variant vaccine could be ready in early 2022

by
November 28, 2021
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

SoftBank posts a $21.6 billion quarterly loss on its Vision Fund, one of the highest in its history

Inflation: Why Mohamed El-Erian is concerned about ‘collateral damage’

Have the markets bottomed, and is it safe to buy? Experts weigh in

China announces fresh military drills around Taiwan

A registered nurse applies a dose of the Moderna COVID-19 vaccine to Sarasota Hospital worker Larry Hammers, 62, at the Sarasota Memorial Hospital in Sarasota, Florida, September 24, 2021.

Shannon Stapleton | Reuters

Moderna’s Chief Medical Officer Paul Burton said Sunday the vaccine maker could roll out a reformulated vaccine against the omicron coronavirus variant early next year.

It’s not clear whether new formulations will be needed, or if current Covid vaccinations will provide protection against the new variant that has begun to spread around the globe.

“We should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the MRNA vaccines, Moderna platform is that we can move very fast,” Burton said on BBC’s “Andrew Marr Show.”

“If we have to make a brand new vaccine I think that’s going to be early 2022 before that’s really going to be available in large quantities,” the Moderna chief added.

Omicron has been classified as a “variant of concern” by the World Health Organization, meaning it is more contagious, more virulent or more skilled at evading public health measures, vaccines and therapeutics. The variant contains 30 mutations to the spike protein that allows the virus to enter the body. Officials have warned that many of these mutations could lead to increased antibody resistance and transmissibility, which could limit the effectiveness of existing Covid vaccines.

The vaccine maker “mobilized hundreds” of workers starting early Thursday morning, on Thanksgiving, to start studying the new variant, the company said in a statement.

Current vaccines could provide some protection, depending on how long ago a person was injected, Burton said. Still, he said unvaccinated people should get vaccinated or receive their booster shots, if eligible.

Next Post

Philly Fed: State Coincident Indexes Increased in 48 States in October

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Breaking News

SoftBank posts a $21.6 billion quarterly loss on its Vision Fund, one of the highest in its history

by
August 8, 2022
0

In this article 9984.T-JP SoftBank's Vision Fund, the brainchild of the company's founder Masayoshi Son, has faced a number of...

Read more

SoftBank posts a $21.6 billion quarterly loss on its Vision Fund, one of the highest in its history

Inflation: Why Mohamed El-Erian is concerned about ‘collateral damage’

Have the markets bottomed, and is it safe to buy? Experts weigh in

China announces fresh military drills around Taiwan

Buffett’s Berkshire Hathaway reports $44 billion loss as portfolio value falls

5 Nasdaq Stocks To Buy And Watch Now: Here Are The Fundamental And Technical Reasons Why

Load More

All rights reserved by www.moneyprofitnews.com

  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

moneyprofitnews